Jesse Mez Selected Research

Chronic Traumatic Encephalopathy

1/2022	Association of APOE Genotypes and Chronic Traumatic Encephalopathy.
1/2022	MicroRNA Alterations in Chronic Traumatic Encephalopathy and Amyotrophic Lateral Sclerosis.
1/2022	A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease.
12/2021	Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project.
10/2021	Validity of the 2014 traumatic encephalopathy syndrome criteria for CTE pathology.
1/2021	National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome.
1/2021	Neuroimaging Biomarkers of Chronic Traumatic Encephalopathy: Targets for the Academic Memory Disorders Clinic.
1/2020	Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy.
1/2018	Cerebrospinal fluid tau, Aβ, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration.
1/2017	CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jesse Mez Research Topics

Disease

18	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 01/2013
12	Dementia (Dementias) 08/2022 - 01/2014
11	Chronic Traumatic Encephalopathy 01/2022 - 07/2015
6	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 01/2014
3	Cognitive Dysfunction 01/2022 - 01/2017
2	Stroke (Strokes) 01/2022 - 01/2019
2	Atrophy 12/2021 - 12/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2018 - 11/2004
1	Breast Neoplasms (Breast Cancer) 06/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Hippocampal Sclerosis 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022
1	Infarction (Infarctions) 01/2022
1	Amyloid Plaque 01/2022
1	Neurobehavioral Manifestations 10/2021
1	Inflammation (Inflammations) 07/2021
1	Memory Disorders (Memory Loss) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Tauopathies 01/2020
1	Overweight 01/2020
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2019
1	Neuroinflammatory Diseases 11/2018
1	Parkinsonian Disorders (Parkinsonism) 01/2018
1	Genetic Risk Score 01/2017
1	Wounds and Injuries (Trauma) 07/2015
1	Ataxia (Dyssynergia) 11/2004
1	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 11/2004
1	Weight Loss (Weight Reduction) 11/2004
1	Neuroblastoma 11/2004

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2019
9	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2013
9	Amyloid (Amyloid Fibrils)IBA 01/2022 - 07/2015
4	ApolipoproteinsIBA 06/2022 - 01/2017
4	TESIBA 12/2021 - 01/2014
3	Amyloid beta-PeptidesIBA 01/2022 - 07/2015
3	Proteins (Proteins, Gene)FDA Link 11/2018 - 01/2017
2	LipidsIBA 03/2022 - 01/2021
2	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022 - 12/2013
2	Biological ProductsIBA 01/2022 - 12/2021
2	Peptides (Polypeptides)IBA 07/2021 - 07/2015
1	Threonine (L-Threonine)FDA Link 10/2022
1	Glucose (Dextrose)FDA LinkGeneric 03/2022
1	5,5-dimethyl-1,2,3-cyclohexanetrione 1,2-dioxime 3-thiosemicarbazoneIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Pharmaceutical PreparationsIBA 07/2021
1	C-Reactive ProteinIBA 07/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	RNA Precursors (Precursor, mRNA)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	LeptinIBA 01/2020
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2019
1	polyglutamineIBA 11/2004
1	Ataxin-3IBA 11/2004
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 11/2004

Therapy/Procedure

1	Precision Medicine 11/2020